Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moor Instruments is a private UK medical device company that designs, manufactures, services, and distributes monitoring and imaging systems for assessing microvascular blood flow and tissue oxygenation. Its products are used across preclinical research, clinical research, and patient-care applications, with particular strength in laser Doppler imaging, laser speckle contrast imaging, tissue oxygen monitoring, and burn wound assessment. The company is known for commercially marketed systems such as moorVMS-LDF, moorVMS-OXY, moorFLPI-2, moorLDI2, moorLDLS-BI, and moorLDI2-BI. Moor states that its burn assessment systems have CE approval and FDA 510(k) clearance for diagnostic use, and the company operates under ISO 13485 quality certification. Overall, Moor Instruments is best understood as a specialized vascular imaging and perfusion-monitoring device manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moor Instruments.